Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.1 USD | -0.21% | +0.48% | +0.55% |
08/05 | Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M | MT |
08/05 | Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.55% | 159.98Cr | |
+16.03% | 7.9TCr | |
+10.23% | 895.73Cr | |
-10.76% | 518.56Cr | |
+51.58% | 476.76Cr | |
+12.50% | 426.22Cr | |
-20.70% | 236.89Cr | |
+12.83% | 229.5Cr | |
-29.65% | 220.86Cr | |
+19.51% | 217.28Cr |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Insider Sell: Supernus Pharmaceuticals